Figure 4From: Cardiovascular safety of exenatide BID: an integrated analysis from controlled clinical trials in participants with type 2 diabetesWeighted Kaplan Meier plot for subjects without a primary MACE event by treatment in controlled studies of exenatide BID.Back to article page